###### Strengths and limitations of this study

-   Iterative modification of the evidence-based components of the intervention will allow us to study how hospitals and specialities adapt and improve the components to meet their site-specific contextual needs.

-   The study will provide a generalisable framework for tailored implementation of post-surgical discharge pain management prescribing best practices to reduce patient and societal harm due to excess opioids without negatively affecting patient reported pain outcomes.

-   Comparison to within site non-intervention controls allows us to control for secular decline in opioid prescriptions, driven by the salience of the 'opioid epidemic' in popular press and public policy.

-   The study duration (3 years) is a relatively short time to expect complete implementation and to observe improvement.

Introduction {#s1}
============

Background and existing literature {#s1a}
----------------------------------

Nearly all surgical procedures result in some level of postoperative pain, although with varying intensity and duration, for which surgical providers prescribe pain medications, often opioids. In our prior study, in a single health system, opioids were prescribed after 95% of surgical procedures.[@R1] Furthermore, we found that the patients only used, on average, a small number of pills (\~5 pills) after elective general surgical procedures,[@R1] confirming prior studies' finding that between 70% to 90% of prescribed opioids after surgery remain unused by the patient.[@R2] It has also been established that only a small fraction of unused opioid pills are properly disposed of[@R6] leaving a substantial number of pills available for potential non-medical use and diversion.[@R5]

Indeed, 50% to 75% of non-medical opioid users obtain the drugs from relatives or friends, a concept known as 'diversion'.[@R10] In 2016, 11.5 million individuals (\>12 years) reported using prescription drugs for a non-medical purpose in the past year.[@R12] Every day, more than 115 people die after overdosing on opioids and, despite recent efforts to curb the crisis, the numbers are still steadily increasing.[@R13] Moreover, opioid related poisoning caused 78 840 hospitalisations and 140 077 emergency department visits in 2015 alone.[@R12] Finally, more than 80% of people who use heroin have a history of non-medical use of pain relievers first.[@R11] Much of the focus has fallen on opioid prescribing by primary care physicians, particularly for chronic opioid use, but surgical providers also have a role in this epidemic, given the overprescribing of opioids after surgery.

While opioid prescriptions written by surgical providers, in 2017, accounted for only 5% of the 191 million dispensed opioid prescriptions in the USA,[@R15] they nevertheless accounted for 10.4 million filled prescriptions.[@R16] Many factors contribute to opioid prescribing decisions for pain control following a surgical procedure, including patient factors (eg, pain tolerance, opioid tolerance), procedural factors (eg, open incision, laparoscopic incision), legal influences (eg, laws that restrict the ability to electronically prescribe or offer refills remotely) and social factors (eg, distance to provider to obtain a refill prescription).[@R3] Research also shows that surgical providers often use a default number of pills (eg, 60 pills after hernia surgery) with little attention to patient factors, often prescribing more pills than needed for the majority of the patients.[@R3]

The role of surgical providers in the opioid epidemic unfolds in three ways[@R1]: (i) overprescribing of opioids following surgery, which leaves unused opioids available for non-medical use and diversion[@R2], (ii) inadequately providing perioperative patient education around safe use and proper disposal of unused opioid pills and expectation setting about post-surgical pain and pain management[@R17] and[@R3] (iii) contributing to the development of chronic post-surgical pain.[@R3]

It is imperative that the numerous factors influencing surgical provider opioid prescribing be addressed while ensuring that the patients still receive adequate post-surgical pain control. Minimising Opioid Prescribing in Surgery (MOPiS) is a multi-component intervention that addresses[@R1] *opioid overprescribing,* for example by promoting baseline assessment of a patient prior to writing any opioid prescription to identify and address duplicative opioid prescriptions (eg, provider use of state prescription monitoring programmes (PMP))[@R2], *optimising pain control* (eg, use of non-opioid analgesics as first-line therapy with opioid supplementation, if needed)[@R49] and[@R3] *minimising reliance on opioid prescriptions for pain control* (eg, familiarisation of providers with evidence on alternatives to opioid analgesics and with the actual number of pills used by the patients for pain management).[@R49]

Study aims {#s1b}
----------

The MOPiS study was developed, based on current evidence and national guidelines, to address four distinct domains[@R1]: expectation setting[@R2], baseline assessment[@R3], optimisation of perioperative non-opioid pain management and[@R4] opioid minimisation at discharge.[@R51]

We will conduct a mixed-methods evaluation of the implementation and effectiveness of MOPiS by[@R1] applying a concurrent, formative evaluation to identify barriers and enablers to implementation[@R2], using the Consolidated Framework for Implementation Research (CFIR)[@R3], performing a quantitative assessment of site-specific effectiveness and[@R4] determining the necessary and sufficient conditions for improving post-surgical opioid prescribing without negatively affecting pain-related patient outcomes.

The study aims are {#s1c}
------------------

### Aim 1: evaluate the implementation of a multi-component intervention to reduce post-surgical opioid prescribing, while ensuring optimal pain control across six hospitals {#s1c1}

Hypothesis 1: Implementation requires site-specific contextual adaptations of the intervention by speciality-specific, multidisciplinary surgical teams.

### Aim 2: assess changes in opioid prescribing and pain-related patient outcomes following implementation of the contextually specific, multi-component intervention {#s1c2}

Hypothesis 2: Implementation of the intervention will lead to decreased post-surgical opioid prescriptions without a decline in patient-reported pain-related outcomes, compared with historical and contemporaneous controls.

### Aim 3: assess the interaction between site-specific contextual factors and variation in the fidelity and intensity of implementation on post-surgical opioid discharge prescribing {#s1c3}

Hypothesis 3: The context of the intervention, as well as, specific approaches to implementing the components of the intervention, will lead to greater improvement.

Theoretical frameworks {#s1d}
----------------------

Implementation of the MOPiS intervention will be guided by the **E**xploration, **P**reparation, **I**mplementation, **S**ustainment (**EPIS**) Framework.[@R56] [Figure 1](#F1){ref-type="fig"} shows the adaptation of the EPIS Framework for MOPiS. In addition, the CFIR[@R55] will be used to comprehensively explore the contextual needs and adaptations of the intervention in order to achieve robust and sustainable implementation at each site.

![Application of EPIS phases to MOPiS Implementation. EPIS, Exploration, Preparation, Implementation, Sustainment; IN, Indiana; IL, Illinois; MOPiS, Minimising Opioid Prescribing in Surgery; PMP, prescription monitoring programmes.](bmjopen-2019-030404f01){#F1}

Study significance {#s1e}
------------------

The MOPiS study will provide a generalisable framework for tailored implementation of post-surgical prescribing best practices to reduce patient and societal harm due to excess opioids without negatively affecting pain-related patient-reported outcomes. The study promotes evidence-based practices to identify effective strategies for contextually specific, system-level change, and it will provide both conceptual and practical insights to inform implementation of a system-level, evidence-based practice intervention in diverse hospitals, across the USA.

Methods and analysis {#s2}
====================

Overview of study design {#s2a}
------------------------

The intervention will be implemented in four surgical areas (general, orthopaedics, urology and gynaecology) at six hospitals within a single health system. We will conduct a mixed-methods evaluation using formative evaluation techniques including qualitative (eg, focus groups, interviews, observations) and quantitative (eg, process and outcome measure performance reports) data collection to identify barriers and facilitators to the implementation and effectiveness of the intervention.[@R57]

Data collection, analysis and interpretation will be continuous before, during and after implementation with identified barriers being fed back iteratively to the hospitals for site-specific contextual adaptations. In addition, we will perform a quantitative evaluation to determine the effectiveness of the intervention to decrease post-surgical discharge opioid prescribing without negatively affecting pain-related patient-reported outcomes. To determine effectiveness, we will also use cases from non-intervention surgical specialities (plastic surgery, vascular surgery and neurosurgery) as contemporaneous within-site controls. Once effective strategies are identified, they will be implemented in the non-intervention specialities for study equipoise. Finally, we will combine the qualitative and quantitative results to ascertain which components of the intervention, in combination with site-specific contextual factors, are most effective in reducing opioid prescribing. The goal is to identify the most effective hospital-type and speciality-specific intervention bundles.

Setting {#s2b}
-------

The study will be conducted at six hospitals within a health system, in Illinois. The hospitals are diverse with significant differences in size, location, population served and level of academical or community focus ([table 1](#T1){ref-type="table"}) and have a single enterprise data warehouse (EDW) for data collection.

###### 

Hospitals and specialities participating in MOPiS

                    Hospital 1       Hospital 2        Hospital 3        Hospital 4        Hospital 5        Hospital 6
  ----------------- ---------------- ----------------- ----------------- ----------------- ----------------- -----------------
  Category          Large academic   Large community   Large community   Small community   Small community   Small community
  Teaching status   Teaching         Non-teaching      Non-teaching      Non-teaching      Non-teaching      Non-teaching
  No of beds        894              198               392               159               98                25

MOPiS, Minimising Opioid Prescribing in Surgery.

Intervention {#s2c}
------------

For each of the four domains, the intervention includes one or more main components:

Patient expectation settingStandardised Patient Education: Patient education materials will be developed with the aim of improving adherence to safe opioid use.[@R29] Educational materials will include printed brochures, as well as, interactive patient modules to educate patients on how to safely use, store and dispose of opioids. All educational material will be user-informed and literacy-level testing will be performed by our patient advisory council.

Baseline assessment of opioid useAutomated IL-PMP Lookup: A key approach to reducing the number of opioids available for diversion is to ensure that the patients cannot access multiple opioid prescriptions simultaneously. The Prescription Monitoring Programme (PMP) is an electronic database that tracks the prescribing and dispensing of controlled substances (Schedule II-V), including opioids, with data on individual patients and individual prescribers.[@R59] Clinicians can log into the PMP to view a patient's prior filled prescriptions. As part of the intervention, the PMP database will be integrated into the electronic health record (EHR) at each hospital to allow for an automated connection and to overcome technical and nuisance barriers associated with manual PMP lookup. Moreover, each time a provider attempts to order opioids, we plan to design an automatic lookup in the Illinois PMP (IL-PMP), so that prior opioid prescriptions will automatically appear next to the new opioid order.

Perioperative pain control optimisationOnline Provider Education: Interactive, web-based, educational modules will be developed to educate providers on safe opioid prescribing, leveraging multimodal pain control strategies, setting pain management expectations with the patients and educating the patients on opioid safety. Content experts in perioperative pain management will help to develop the modules. The modules will be targeted toward all surgical care providers, including surgeons, advanced practice providers, nurses and pharmacists.

Postoperative opioid minimisationElectronic Health Record-based CDS Tools: Computerised decision support (CDS) tools can change prescribing behaviour, prevent medical errors and improve evidence-based clinical practice.[@R60] We will gather procedure-specific opioid use data and combine this with existing evidence for procedure-specific prescribing guidelines to develop guidelines for *appropriate* prescription opioid quantity by procedure. Discharge order sets will incorporate the recommended quantity as a default. Surgical providers will retain the option of increasing the quantity of opioid pills by providing a brief explanation. Additionally, the discharge order sets will also include pain management order sets with non-opioid pain management alternatives (eg, ibuprofen, ice packs).Monthly Comparative Prescribing Reports: We will develop automated monthly comparative prescribing reports for individual surgical providers, detailing their prescribing data compared with blinded peer data and compared with prescribing recommendations by surgical procedure.

Adaptation of intervention components

We anticipate variation in the extent to which each hospital and each speciality adapts the intervention components, depending on hospital and speciality-specific contextual factors. The formative evaluation of MOPiS, conducted throughout the study timeframe, will enable the identification and documentation of hospital- and speciality-specific adaptations and improvements to the components to meet hospital- and speciality-specific contextual needs.

Characteristics of study participants {#s2d}
-------------------------------------

To study the systems and processes of care involved in post-surgical pain medication prescribing, including opioid prescribing, surgical providers and staff participating in the implementation will be research study participants. Surgical providers and staff, as participants in the qualitative data collection, will be identified using purposive sampling, based on subject matter expertise. Additionally, the patients will be interviewed. Potential patient participants will be identified by the surgical providers. English-speaking adults of any gender and ≥18 years of age who are willing to speak about their experience with the implementation of preoperative opioid education and expectation setting and post-surgical pain management will be invited to participate. Patients will be interviewed until saturation of themes is reached.

In addition, quantitative data about the patients who have undergone selected surgical procedures at each of the participating hospitals will be gathered for both intervention and control specialities, using a survey and electronic data abstraction from the EDW.

Patient and public involvement {#s2e}
------------------------------

To ensure that patient education materials are patient and family-centred, the health system's patient advisory council will review materials. Additionally, advisory panel members, including a patient safety foundation representative, will provide feedback on study materials and findings, and will support dissemination efforts.

Data collection components {#s2f}
--------------------------

-   *Readiness Assessment:* Prior to implementation, we will conduct a survey to assess the readiness of each hospital and each speciality to implement the necessary process changes and to identify additional needed resources. The survey will be conducted among all surgical providers involved in the implementation of the intervention.

-   *Interviews:* We will conduct semi-structured confidential interviews with key stakeholders at each hospital and within each speciality to include, but not be limited to, clinic nurses, post-anaesthesia care unit (PACU) nurses, surgeons, advanced practice nurses, physician assistants, pharmacists and surgical residents (where applicable). Interview questions will focus on assessing the local adaptation and implementation of each intervention component, as well as, the individual's perceptions of the utility of each component. We will specifically inquire about barriers to change, including questions about the culture and work environment, in order to gain input about any site-specific barriers and facilitators during implementation.

-   *Focus Groups:* During the implementation phase, we will conduct focus groups at each hospital, using a set of structured questions to guide the discussion. Focus group participants will include an attending physician, a PACU nurse, an outpatient clinic nurse, a resident or physician assistant where applicable and a representative from each speciality's administrative leadership. Each focus group will consist of six to eight participants and last for approximately 1 hour. The data from the focus groups will provide important information about issues related to the division's participation in the intervention.

-   *Observations:* We will conduct a series of *ethnographical observations* of preoperative clinical encounters at each hospital to help us understand hospital and speciality-specific contextual factors that affect the adaptation and implementation of the preoperative components (eg, observe the functioning of a preoperative clinic and patient encounter).[@R64] The observer will assume the role of 'peripheral-member researcher,' which brings an 'outsider's perspective' to the observation to allow for accurate appraisal of activities. The site visit team will collect data using a semi-structured observation tool.[@R67] We will use observation to assess the patient exposure to the intervention components.

-   *Patient Interviews:* We will conduct interviews with a random selection of patients in each hospital to ask the patients about their experiences with, and exposure to, opioid education, expectation setting and post-surgical pain management to provide *real-time* patient satisfaction and exposure data to the implementation team.

-   *Medical Chart Abstraction:* Using data abstraction queries from the system-wide enterprise data warehouse (EDW), we will develop an automated report to identify prescribing patterns and process measure adherence by domain of optimal use, as detailed in [table 2](#T2){ref-type="table"}. In addition, the EDW will generate information on hospital characteristics and contextual factors. To validate the EDW data and any data that cannot be queried through the EDW, certified data abstractors will conduct manual chart reviews on a random sample of eligible patient charts.

###### 

Process measures for optimal postoperative opioid use

  Setting                                                                           Domain                                                       Process measure                   Measure                                                                Implementation outcomes   Variable type
  --------------------------------------------------------------------------------- ------------------------------------------------------------ --------------------------------- ---------------------------------------------------------------------- ------------------------- ---------------
  Preoperative                                                                      Expectation setting                                          Preoperative narcotic education   Preoperative education documented in preop note or preop clinic note   Fidelity                  dichotomous
  Opioid education tool distributed                                                 Fidelity                                                     dichotomous                                                                                                                        
  Observation (5 to 10 clinic appointments)                                         Exposure                                                     qualitative                                                                                                                        
  Baseline assessment                                                               Chronic opioid use investigated                              PMP user look-up registry         Fidelity                                                               dichotomous               
  Chronic pain addressed                                                            Chronic pain tool distributed                                Fidelity                          dichotomous                                                                                      
  Referral to pain specialist                                                       Fidelity                                                     dichotomous                                                                                                                        
  Addiction risk assessment                                                         NIDA risk screen performed (preop documentation)             Fidelity                          dichotomous                                                                                      
  Perioperative                                                                     Optimising pain control (minimising opioid use)              Preoperative analgesic given      EMR MAR from OR or anaesthesia record                                  Exposure                  dichotomous
  Pre-incision local anaesthetic                                                    Dictated in operative note                                   Exposure                          dichotomous                                                                                      
  Anaesthesia type                                                                  Anaesthesia Record                                           Exposure                          categorical                                                                                      
  Anaesthesia adjuncts (eg, regional block, epidural, intravenous lidocaine, etc)   Anaesthesia record                                           Exposure                          categorical                                                                                      
  Multimodal pain control                                                           EMR MAR from inpatient stay                                  Exposure                          dichotomous                                                                                      
  Postoperative                                                                     Opioid minimisation                                          Consult PMP                       PMP user look-up registry (monthly per 100 patients)                   Fidelity                  dichotomous
  Communicate with PCP                                                              Documentation in discharge record of coordination with PCP   Fidelity                          dichotomous                                                                                      
  Discharge education information provided                                          Post-surgical pain handout provided                          Fidelity                          dichotomous                                                                                      
  Documentation of education in discharge record                                    Fidelity                                                     dichotomous                                                                                                                        

EMR, electronic medical record; MAR, medication administration record; NIDA, National Institute on Drug Abuse; OR, operating room; PCP, primary care physician; PMP, prescription monitoring programmes.

-   *Patient Surveys:* We will use online surveys to collect pain-related patient-reported outcomes among the patients who have undergone selected surgical procedures at each of the participating hospitals within the intervention and control specialities. Patients will be asked to rate their pain (0 to 10) daily for the first 7 days following discharge and, the morning of each day (postoperative day 2 to 8), they will be asked to report the number of opioid pills consumed in the prior 24 hours. The Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Short Form will be administered using computerised adaptive testing preoperatively, and then at 2 weeks, 3 months, 6 months and 1 year post-surgically.

[Table 3](#T3){ref-type="table"} provides a summary of the different data collection components.

###### 

Summary of data collection components and measures

  Data collection component   Implementation phase (EPIS framework)   Measures         
  --------------------------- --------------------------------------- ---------- -- -- ------------------------------------------------------------------------------------------------
  Readiness assessment                                                                 Readiness to implement, resources needed
  Observations                                                                         Patient exposure to education and expectation setting
  Provider interviews                                                                  Perceptions of implementation barriers, process, safety culture and intervention effectiveness
  Focus groups                                                                         Issues related to division's participation in intervention
  Patient interviews                                                                   Patient exposure to education and expectation setting, patient satisfaction
  Medical chart abstraction                                                            Implementation process measure adherence([table 2](#T2){ref-type="table"})
  Patient surveys                                                                      Patient-reported pain scores, opioid storage and disposal behaviours
  Secondary data sources                                                               Hospital characteristics

EPIS, Exploration, Preparation, Implementation, Sustainment.

-   *Secondary Data Sources:* Data on hospital characteristics will be obtained from the American Hospital Association Annual Hospital Survey and the Centres for Medicare and Medicaid Services Payment Update Impact Files, including: bed size, discharge volume, surgical case volume, resident-to-bed ratio/teaching status, ownership, case mix index, core-based statistical area and nurse-to-bed ratio.

Data analyses {#s2g}
-------------

### Measures of intervention effectiveness {#s2g1}

-   The primary outcome will be the number of pills prescribed per surgical case (patient/case-level measure).

-   Secondary outcomes include the strength, quantity and formulation of each post-surgical opioid prescribed, converted to morphine milligram equivalents.

-   The electronical survey will use PROMIS Pain Intensity Short Form questions that capture how pain interferes with a patient's quality of life over the preceding 7 days. This will function as a balancing measure to assess potential negative impacts of the intervention.

Quantitative data analysis {#s2h}
--------------------------

We will perform a quantitative evaluation to determine the effectiveness of the intervention to decrease post-surgical discharge opioid prescribing without negatively affecting patient-reported pain outcomes.*Change in Opioid Prescribing:* A comparison of the mean number of pills prescribed per case post-intervention (Years 2 and 3) compared with pre-intervention (Year 1) will be performed, clustered within surgeons, specialities and hospital. Because the intervention is at the system-level and the cluster size may not support three or four levels of clustering, analyses will be designed to account for the 24 clusters at the site-speciality level ([table 1](#T1){ref-type="table"}). First, we will assess pre- and post-intervention differences in mean number of pills prescribed per case, using a one-sided paired Student's t-test with clustered SE (or Wilcoxon rank-sum test for non-normally distributed data) to test the hypothesis that our intervention will reduce the mean number of pills prescribed per case. We will also use statistical models with controls for patient, speciality and hospital characteristics. We will explore several models to assess appropriateness and robustness of findings across specifications. Approaches may include a linear ordinary least squares fixed effects regression model of the form:

$$Y_{ijt} = \alpha + \beta_{1}Year2 + \beta_{2}Year3 + \theta X_{ijt} + \gamma SpecialtySite_{j} + u_{ijt}$$

where $Y_{ijt}$ is the number of pills prescribed for each case *i,* in speciality-site *j,* in year *t*; $\alpha$ is an intercept, $\beta_{1}$ and $\beta_{2}$ are coefficients on dummy variables indicating cases from the post-intervention period, $X_{ijt}$ is a vector of patient covariates and $SpecialtySite_{j}$ is a set of 23 speciality-site indicators ("fixed effects") which control for all time-invariant speciality-site characteristics, measured and unmeasured, that only vary across speciality-sites but are invariant within. In effect, this conservatively controls for all between-speciality-site differences and identifies treatment differences within sites. We hypothesise that the intervention will reduce the number of prescribed pills per case, thus we anticipate $\beta_{1}$\<0 and $\beta_{2}$\<0. A more stringent test of sustained improvement over time implies that $\beta_{2}\& lt;\beta_{1}\& lt;0$. Because fixed effects linear models preclude the inclusion of any speciality-site covariates that may be of interest, we will also explore estimation of two-level hierarchical linear models with speciality-site random intercepts.*Intervention Effect on Case-Level Patient-Reported Outcomes Measurement Information System Pain Intensity Short Form Pain Scores:* Pre-post and difference-in-differences, as outlined above, will be calculated. However, we hypothesise that the coefficients on study year will not be statistically different from zero.Sensitivity Analyses: We will do several sensitivity analyses, including[@R1]: with and without inclusion of patient and speciality covariates in the models[@R2]; examining the association between hospital, surgical speciality, procedural characteristics and missing data and[@R3] examining spillover effects by assessing operations within the hospital similar to those studied but performed by surgeons outside of the targeted specialities, serving as contemporaneous controls (eg, emergency general surgery or acute care surgery procedures).Power Calculations: The sample size is expected to be stable in the four specialities in each hospital ([table 1](#T1){ref-type="table"}). On average, we expect approximately 1888 cases per speciality by site. We conducted a baseline assessment of opioid prescribing and found a mean of 30 pills and SD of 10. Assuming a baseline prescription rate of 30 pills per case, a conservative hypothetical estimate of speciality by site intra-cluster correlations of 0.2, alpha = 0.05 and power = 80%, we anticipate being able to detect a minimal difference of 4.58 pills in mean rates before-and-after the intervention if the SD remains 10. This would increase to a minimum detectable decrease of 9.16 pills assuming SD = 20, or minimal detectable difference of 16.21 pills if the SD = 50.

Measures of implementation effectiveness {#s2i}
----------------------------------------

-   *Feasibility:* Conducting pre-implementation interviews with key stakeholders at each hospital will provide important information about perceived barriers to the intervention and whether interviewees think it will be possible to implement the intervention.

-   *Fidelity:* Throughout the implementation, we will use data from the EDW queries to measure the extent to which each component is actually implemented, using the process measures noted above. Fidelity of implementation will also be assessed through the preoperative clinic observations.

-   *Exposure:* The degree to which the intervention components were actually experienced by the patient will be measured through data abstracted from the EDW, observations of preoperative clinic encounters and patient surveys.

-   *Intensity*: We will estimate a summary score, based on clinician and patient surveys, observations and focus groups.

### Qualitative comparative analysis {#s2i1}

In the final phase of the study, we will assess which components of the intervention, in combination with site-specific contextual factors, are most effective in reducing opioid prescribing. Specifically, we will conduct Qualitative Comparative Analysis (QCA) by combining the results of the qualitative and quantitative data to identify the necessary and sufficient conditions for improved opioid prescribing while preventing negative pain-related patient outcomes.

Using QCA, we will be able to identify more than one causal pathway to the outcome of interest (eg, reducing opioid prescribing) and identify *conjunctional causation* or the conditions that may only display their effects in conjunction with other conditions. QCA is a case-oriented mathematical approach that examines relationships between conditions and an outcome.[@R70] QCA answers the question: what conditions, alone or in combination with other conditions, are necessary or sufficient to produce the outcome of interest? *Data:* The first step in QCA is to develop a conceptual model, based on input from the qualitative results. The transcripts from the surveys, interviews and observations will be coded and analysed to identify potential causal relationships. The research team will use a computer-assisted qualitative data analysis software (MAXQDA) to support the analysis. During analysis, categorical themes will be identified and applied to further transcripts. We will conduct a hybrid form of textual analysis which combines both inductive and deductive logics.[@R71] The analytical strategy will be informed by the task at hand (assessment of the implementation of the intervention), as well as, the desire to allow unanticipated themes to emerge from the data and to allow participant understandings to be revealed, as in our prior work.[@R73] Themes identified from the qualitative research will provide insight into site-specific implementation adaptations and how participants anticipate implementation of the intervention to reduce opioid prescribing while effectively controlling post-surgical pain. Results of the analysis will be used to build the QCA conceptual model. The conceptual model will emphasise the *conditions* that need to be in place, either individually or in combination, for the intervention to be effective at a specific hospital (ie, the necessary conditions) and what conditions, either individually or in combination, would produce the outcome in a specific hospital (ie, sufficient conditions). For example, using the results of the qualitative research, we might find the conditions most likely to influence implementation success include use of a surgeon champion, engaged staff, safety culture, engaged patients and strong organisational leadership. [Figure 2](#F2){ref-type="fig"} illustrates a hypothetical example that considers the necessary and sufficient set-theoretical relationships. As shown in the figure, necessary conditions must be present for an outcome to occur.

![Example of present and absent conditions for outcomes to occur.](bmjopen-2019-030404f02){#F2}

-   *Analysis*: Crisp-set QCA analysis will be used to dichotomise the conditions for each hospital as either 'having' or 'not having' each condition. Data from the 24 sites within the six hospitals will be rank-ordered from highest to lowest on two outcomes (opioid prescriptions and pain-related patient measures). A 'truth table' will be constructed to assess whether all logically possible configurations have empirical cases. At the conclusion of the truth table analysis, we will return to the qualitative data to provide rich examples of the cases.

-   *Sensitivity Analyses:* Sensitivity analyses will examine relationships between change scores and numerous formulations of the domain-specific implementation scores to assess the robustness of the findings.

Ethics and dissemination {#s3}
========================

In this study, we describe the protocol for implementation and evaluation of a multifaceted opioid minimisation intervention. The study aims to identify the most effective hospital-type and speciality-specific intervention bundles for rapid dissemination into our 56-hospital learning collaborative and in hospitals throughout the USA. Dissemination activities will be further supported by our External Advisory Panel which includes public health leaders at the federal, state and city levels, as well as experts in medication diversion and addiction, public safety and health and drug policy and patient advocacy. Furthermore, findings will be disseminated through a combination of traditional approaches (peer-reviewed publications and conference presentations) and newer technology-driven approaches (social media accounts, websites and webinars). Dissemination materials will be prepared as soon as data are available and when analyses have been finalised.
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